Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
MDXH
#6632
MDxHealth SA Ordinary Shares
3.4
0
-9.09%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-9.09%
Changement Mensuel
-8.11%
Evolution sur 6 mois
-5.29%
Changement Annuel
+85.79%
Clôture Précédente
3.7
4
Open
3.4
0
Bid
Ask
Low
3.4
0
High
3.4
0
Volume
3
Marchés
Actions des Marchés US
Soins de Santé
MDXH
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
Q4, 24
TTM
Key stats
Total common shares outstanding
49.5 M
92.38 M
Valuation ratios
Enterprise value
117.31 M
—
Price to earnings ratio
—
—
Price to sales ratio
—
—
Price to cash flow ratio
—
—
Price to book ratio
—
—
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
—
—
Return on equity %
—
—
Return on invested capital %
—
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
—
—
Current ratio
—
—
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
—
—
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
—
—
Net current asset value per share
—
—
Tangible book value per share
—
—
Working capital per share
—
—
Book value per share
—
—
Nouvelles
3 Best Stocks to Buy Today with 125%+ Upside, 2/27/2026, According to Top Analysts - TipRanks.com
MDxHealth SA (MDXH) Q4 2025 Earnings Call Transcript
MDxHealth ADR earnings missed by $0.04, revenue fell short of estimates
MDxHealth annonce une croissance de 23% de son chiffre d’affaires au T4 et ses prévisions pour 2026
MDxHealth reports 23% revenue growth in Q4, issues 2026 guidance
BTIG réitère sa recommandation d’achat sur MDxHealth avec un objectif de 7,00€
BTIG reiterates Buy rating on MDxHealth stock, maintains $7 price target
L’objectif de prix de l’action MDxHealth relevé à 7$ contre 6$ par BTIG
MDxHealth stock price target raised to $7 from $6 at BTIG on growth outlook
MDxHealth SA (MDXH) Q3 2025 Earnings Call Transcript
Le BPA de MDxHealth ADR a manqué les attentes de 0,05$, le CA en dessous des prévisions
MDxHealth ADR earnings missed by $0.05, revenue fell short of estimates